Derivative Financial Instruments - Warrants (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Changes in the Company's derivative financial instruments liability balance
Balance of warrants outstanding at the beginning of the period (in shares)	5,505,901
Balance of warrants outstanding at the end of the period (in shares)	5,505,901
Balance of derivative financial instruments liability at the beginning of the period	$ 834,940
Change in fair value of warrants during the period recognized as a gain in the condensed consolidated statement of operations	(555,506)	$ (533,750)
Balance of derivative financial instruments liability at the end of the period	$ 279,434
Warrants | Black Scholes Option Pricing Method
Range of assumptions used to determine the fair value of warrants
Dividend yield (as a percent)	0.00%	0.00%
Changes in the Company's derivative financial instruments liability balance
Balance of warrants outstanding at the beginning of the period (in shares)	967,295
Balance of warrants outstanding at the end of the period (in shares)	967,295
Balance of derivative financial instruments liability at the beginning of the period	$ 834,940
Balance of derivative financial instruments liability at the end of the period	$ 279,434
Warrants | Black Scholes Option Pricing Method | Minimum
Range of assumptions used to determine the fair value of warrants
Estimated fair value of Trovagene common stock (in dollars per share)	$ 1.15	$ 5.69
Expected warrant term	1 year 9 months	3 years 3 months 18 days
Risk-free interest rate	1.20%	0.89%
Expected volatility (as a percent)	94.00%	75.00%
Warrants | Black Scholes Option Pricing Method | Maximum
Range of assumptions used to determine the fair value of warrants
Estimated fair value of Trovagene common stock (in dollars per share)	$ 2.10	$ 10.15
Expected warrant term	2 years	3 years 9 months 18 days
Risk-free interest rate	1.27%	1.01%
Expected volatility (as a percent)	98.00%	77.00%